| 1 |
27530729 | Effect of pioglitazone on metabolic features in endotoxemia model in obese diabetic db/db mice. | 2017 Jun |
1 |
| 2 |
19738399 | Subtherapeutic dose of pioglitazone reduces expression of inflammatory adipokines in db/db mice. | 2009 |
2 |
| 3 |
16606335 | Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice. | 2006 Apr |
1 |
| 4 |
16894240 | The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. | 2006 Nov |
1 |
| 5 |
12732191 | Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-gamma. | 2003 May 23 |
4 |
| 6 |
14611672 | Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand. | 2003 Nov |
2 |
| 7 |
1538716 | Enhancement of adipocyte differentiation by an insulin-sensitizing agent. | 1992 Feb |
1 |